Tridek-One
We develop first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseases
12 employees · est. 2018 · Paris, France
XBiotech USA, Inc.
Next Generation Antibody Therapy
97 employees · est. 2005 · Austin, United States
XBiotech USA, Inc. is the older company (2018 vs 2005); XBiotech USA, Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | Tridek-One | XBiotech USA, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2018 | 2005 older |
| Headquarters | ||
| Headquarters | Paris, France | Austin, United States |
| Employees | ||
| Employees | 12 | 97 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Life Sciences | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series Unknown | Not tracked yet |
| Total Funding | ||
| Total Funding | $19.00M | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 2 | Not tracked yet |
| Services | ||
| Services | Development of first-in-class CD31 checkpoint agonists for the treatment of autoimmune and inflammatory diseases. | Not tracked yet |
| Target Customers | ||
| Target Customers | Patients with autoimmune and inflammatory diseases, healthcare providers, pharmaceutical companies, and biotech research institutions. | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Immunomodulation, Therapeutic Antibodies, Autoimmune Diseases, Inflammatory Disorders, Biopharmaceuticals, Immunotherapy, Drug Development, Immune Checkpoint Modulation, Monoclonal Antibodies, Immunological Research, Therapeutic Innovation, Immune System Modulation, Clinical Development, Autoimmune Therapy | Biopharmaceuticals, Antibody Therapy, True Human™ Antibodies, Oncology, Inflammatory Conditions, Infectious Diseases, Clinical Trials, Drug Development, Therapeutic Antibodies, Immunotherapy, Precision Medicine, Disease Treatment, Medical Research, Immunology |
| Website | ||
| Website | tridekone.com | xbiotech.com |
About Tridek-One
Tridek-One is a French biotechnology startup founded in 2018, specializing in the development of first-in-class therapeutic agonistic monoclonal antibodies targeting immune checkpoint inhibitory receptors for the treatment of autoimmune and inflammatory diseases. The company's focus on anti-CD31 ago...
About XBiotech USA, Inc.
XBiotech USA, Inc. is a pioneering global biosciences company specializing in the discovery, development, and commercialization of therapeutic antibodies using its True Human™ proprietary technology. Unlike traditional antibody therapies, XBiotech’s True Human™ antibodies are derived from individual...
We will tell you when either one moves
BounceWatch watches Tridek-One and XBiotech USA, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Tridek-One and XBiotech USA, Inc. — by email.
Frequently Asked Questions
Compare Tridek-One with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Tridek-One on 7 Jun 2025, and XBiotech USA, Inc. on 16 Nov 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.